CLINICAL_TRIALS
research
· 2019-02-15
Clinical Trial Update: Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast Cancer [Phase 2]
Summary
Phase 2 clinical trial update on local treatment (stereotactic body radiotherapy and surgery) for estrogen receptor–positive, HER2-negative oligo-metastatic bre…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Gangnam Severance Hospital | Conditions: Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: UNKNOWN